First Eczema Biologic Debuts but Price Could Restrict Use
May 9, 2017
The US Food and Drug Administration has approved the first biologic therapy for atopic dermatitis, the itchy skin condition better known as eczema.
Continue reading here.
Enhanced cryo–electron microscopy promises to bring previously elusive proteins into view.
AI-guided redesign of protein alphabet in bacteria could unlock new ways to build synthetic organisms.